Semaglutide is a GLP-1 receptor agonist, a class of drugs that has two benefits: controlling blood sugar levels in adults with type 2 diabetes and weight loss in people with or without type 2 diabetes when used with diet and exercise
Cancer Res (2015) 75(3):55465
Important Safety Information Please review full Prescribing Information: Wegovy Prescribing Information For complete safety information, including boxed warnings, contraindications, and potential side effects, refer to the manufacturers prescribing information
Special Considerations for Different Groups People With Kidney Disease Research shows mixed results in people with severe kidney disease
Tirzepatide mimics the action of your naturally occurring hormones GLP-1 and GIP, which help regulate insulin release, improve blood sugar control, and reduce appetite
The MHRA collects and monitors information on suspected safety concerns through its Yellow Card scheme